Boston Scientific records loss on write-down

A one-time charge of $1.8 billion relating to Boston Scientific Corp.'s recalled heart devices forces the company to report a first-quarter loss that nearly equals sales for the period
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.